Biden vows enough vaccine for all American adults by end of May

President Joe Biden said Tuesday that the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated, as his administration announced that drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved shot.

With the bolstered supply, Biden also announced he would be using the powers of the federal government to direct all states to prioritize vaccinating teachers, and said the federal government would provide the doses directly through its pharmacy program.

He challenged states to administer at least one dose of the vaccine to all teachers by the end of March as part of his administration’s efforts to reopen more schools across the nation.

“We’re now on track to have enough vaccine supply for every adult in America by the end of May,” said Biden, who likened the partnership between the two drug companies to the spirit of national cooperation during World War II.

BREAKING—Joe Biden: “This country will have enough vaccine supply for every adult in America by the end of May.”

That is a timeline acceleration!

That means US could soon start donating vaccines this summer to other countries.#COVID19Vaccine #COVID19
pic.twitter.com/cKCuZxQiNb

— Eric Feigl-Ding (@DrEricDing) March 2, 2021

The announcement comes as the White House looks to speed the production of the single-dose J&J vaccine and accelerate the nation’s plans to reach “herd immunity” in the U.S. and begin restoring normalcy after the pandemic.

Biden noted that vaccine supply was only one bottleneck toward that goal, and that the new challenge will be injecting doses into arms as swiftly as possible.

To that end, the Biden administration told governors Tuesday to prepare for their supplies of vaccine to continue to climb over the coming weeks. Additional doses are also heading toward a federally backed program to administer doses in more accessible retail pharmacies.

Those pharmacies will be key in getting the vaccines into the arms of teachers, which will help reopen schools to better educate students who have been at risk of falling behind during the pandemic.

“Let’s treat in-person learning as the essential service that it is,” Biden said.

Biden had originally suggested that the supply would be enough to vaccinate every adult American by the end of July.

But despite the good news, he was leery of predicting when the nation would return to normal. He said, “My hope is by this time next year we’re going to be back to normal,” adding that he maybe it could come sooner.

Officials have said J&J faced unexpected production issues with its vaccine and produced only 3.9 million doses ahead of its receiving emergency use authorization on Saturday. The company has promised to deliver 100 million doses by the end of June.

White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing the supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously. States will also receive 2.8 million doses of the J&J shot this week.

On a call with governors Tuesday, White House coronavirus coordinator Jeff Zients said states should prepare for administering 16-17 million total weekly doses of Pfizer and Moderna vaccines by the end of March, climbing to 17-18 million weekly by early April.

The supply of J&J doses to states, expected to dip after the initial shipment this week, will climb to 4-6 million weekly doses by the end of March and 5-6 million doses weekly through the end of April.

More than 800,000 doses of the J&J vaccine will also be distributed this week to pharmacies to administer in a separate federally-run program that also includes 2.4 million doses of the other two shots.

Both figures are expected to steadily increase, as the White House increasingly looks to the capacity of pharmacy chains like CVS and Walgreens to help speed the nation’s mass vaccination campaign.

Facing questions about the company’s slipping delivery schedule, J&J Vice President Richard Nettles told lawmakers on Capitol Hill last week that the company had faced “significant challenges” because of its “highly complex” manufacturing process.

The assistance from Merck was expected to help J&J meet its production commitments and expand supply even further, but the administration did not immediately provide specifics.